Peng Lab focuses on the molecular and cellular mechanisms of alpha-synuclein and tau related neurodegenerative diseases including but not limited to Parkinson’s disease, Alzheimer’s disease and multiple system atrophy. It is developing cutting edge disease models and applying powerful genetic, multi-omics, structural and high through-put screen methods to investigate a wide range of topics related to the development and progression of this group of diseases. Peng Lab particularly interested in the transmission and conformational diversity of pathological proteins in the central nervous system and the role of neuron-glial interactions in this process.
Contact: Dr. Chao Peng at email@example.com for more information.
Peng Lab Members:
Chao Peng, PhD (Director of Peng Lab)
Shujing Zhang, PhD